ACADIA Pharmaceuticals Inc (ACAD)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 732,793 | 431,755 | 400,413 | 540,894 | 627,009 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $732,793K)
= 0.00
The debt-to-capital ratio for ACADIA Pharmaceuticals Inc remained consistent at 0.00 from December 31, 2020, through December 31, 2024. This indicates that the company had no debt compared to its total capital during this period. A debt-to-capital ratio of 0.00 suggests that the company primarily relies on equity financing rather than debt financing to fund its operations and investments. This may indicate a strong financial position with lower financial risk, as the absence of debt obligations can lead to greater financial flexibility and resilience during challenging economic conditions.
Peer comparison
Dec 31, 2024